Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel

PR2 Overexpression of MAVS stimulates antitumor immunity and significantly reduces tumor growth of immune-insensitive colorectal cancer in vivo.

Publication ,  Conference
Hwang, B-J; Tsao, L-C; DeLeon, G; Wei, J; Yang, X-Y; Lei, G; Wang, T; Morse, MM; Lyerly, HK; Hartman, ZC
Published in: Cancer Immunology Research
March 1, 2020

Duke Scholars

Published In

Cancer Immunology Research

EISSN

2326-6074

ISSN

2326-6066

Publication Date

March 1, 2020

Volume

8

Issue

3

Start / End Page

53 / 54

Publisher

AMER ASSOC CANCER RESEARCH

Related Subject Headings

  • 1115 Pharmacology and Pharmaceutical Sciences
  • 1112 Oncology and Carcinogenesis
  • 1107 Immunology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hwang, B.-J., Tsao, L.-C., DeLeon, G., Wei, J., Yang, X.-Y., Lei, G., … Hartman, Z. C. (2020). PR2 Overexpression of MAVS stimulates antitumor immunity and significantly reduces tumor growth of immune-insensitive colorectal cancer in vivo. In Cancer Immunology Research (Vol. 8, pp. 53–54). AMER ASSOC CANCER RESEARCH.
Hwang, Bin-Jin, Li-Chung Tsao, Gabriel DeLeon, Junping Wei, Xiao-Yi Yang, Gangjun Lei, Tao Wang, Michael M. Morse, Herbert Kim Lyerly, and Zachary Conrad Hartman. “PR2 Overexpression of MAVS stimulates antitumor immunity and significantly reduces tumor growth of immune-insensitive colorectal cancer in vivo.” In Cancer Immunology Research, 8:53–54. AMER ASSOC CANCER RESEARCH, 2020.
Hwang B-J, Tsao L-C, DeLeon G, Wei J, Yang X-Y, Lei G, et al. PR2 Overexpression of MAVS stimulates antitumor immunity and significantly reduces tumor growth of immune-insensitive colorectal cancer in vivo. In: Cancer Immunology Research. AMER ASSOC CANCER RESEARCH; 2020. p. 53–4.
Hwang, Bin-Jin, et al. “PR2 Overexpression of MAVS stimulates antitumor immunity and significantly reduces tumor growth of immune-insensitive colorectal cancer in vivo.Cancer Immunology Research, vol. 8, no. 3, AMER ASSOC CANCER RESEARCH, 2020, pp. 53–54.
Hwang B-J, Tsao L-C, DeLeon G, Wei J, Yang X-Y, Lei G, Wang T, Morse MM, Lyerly HK, Hartman ZC. PR2 Overexpression of MAVS stimulates antitumor immunity and significantly reduces tumor growth of immune-insensitive colorectal cancer in vivo. Cancer Immunology Research. AMER ASSOC CANCER RESEARCH; 2020. p. 53–54.

Published In

Cancer Immunology Research

EISSN

2326-6074

ISSN

2326-6066

Publication Date

March 1, 2020

Volume

8

Issue

3

Start / End Page

53 / 54

Publisher

AMER ASSOC CANCER RESEARCH

Related Subject Headings

  • 1115 Pharmacology and Pharmaceutical Sciences
  • 1112 Oncology and Carcinogenesis
  • 1107 Immunology